openPR Logo
Press release

Cushing’s Disease Treatment Market Expecting Worldwide Growth by 2025

02-21-2018 02:02 PM CET | Health & Medicine

Press release from: Persistence Market Research

Cushing’s Disease Treatment Market Expecting Worldwide

Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease is also caused due to excess production of hypothalamus corticotropin releasing hormone (CRH) which stimulates the synthesis of cortisol by the adrenal glands. The condition is named after Harvey Cushing, the doctor who first identified the disease in 1912. Cushing disease results in Cushing syndrome. Cushing syndrome is a group of signs and symptoms developed due to prolonged exposure to cortisol.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/14155

Signs and symptoms of Cushing syndrome includes hypertension, abdominal obesity, muscle weakness, headache, fragile skin, acne, thin arms and legs, red stretch marks on stomach, fluid retention or swelling, excess body and facial hair, weight gain, acne, buffalo hump, tiredness, fatigue, brittle bones, low back pain, moon shaped face etc. Symptoms vary from individual to individual depending upon the disease duration, age and gender of the patient.  Disease diagnosis is done by measuring levels of cortisol in patient’s urine, saliva or blood. For confirming the diagnosis, a blood test for ACTH is performed. The first-line treatment of the disease is through surgical resection of ACTH-secreting pituitary adenoma, however disease management is also done through medications, Cushing disease treatment market comprises of the drugs designed for lowering the level of cortisol in the body. Thus patients suffering from Cushing disease are prescribed medications such as ketoconazole, mitotane, aminoglutethimide metyrapone, mifepristone, etomidate and pasireotide.

Cushing’s disease treatment market revenue is growing with a stable growth rate, this is attributed to increasing number of pipeline drugs. Also increasing interest of pharmaceutical companies to develop Cushing disease drugs is a major factor contributing to the revenue growth of Cushing disease treatment market over the forecast period. Current and emerging players’ focuses on physician education and awareness regarding availability of different drugs for curing Cushing disease, thus increasing the referral speeds, time to diagnosis and volume of diagnosed Cushing disease individuals.

Growing healthcare expenditure and increasing awareness regarding Cushing syndrome aids in the revenue growth of Cushing’s disease treatment market. Increasing number of new product launches also drives the market for Cushing’s disease Treatment devices. However availability of alternative therapies for curing Cushing syndrome is expected to hamper the growth of the Cushing’s disease treatment market over the forecast period.

Cushing’s disease treatment market revenue is expected to grow at a good growth rate, over the forecast period. The market is anticipated to perform well in the near future due to increasing awareness regarding the condition. Also the market is anticipated to grow with a fastest CAGR over the forecast period, attributed to increasing investment in R&D and increasing number of new product launches which is estimated to drive the revenue growth of Cushing’s disease treatment market over the forecast period.

Depending on geographic region, the Cushing’s disease treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific (APAC) and Middle East & Africa (MEA).

North America is occupying the largest regional market share in the global Cushing’s disease treatment market owing to the presence of more number of market players, high awareness levels regarding Cushing syndrome. Healthcare expenditure and relatively larger number of R&D exercises pertaining to drug manufacturing and marketing activities in the region. Also Europe is expected to perform well in the near future due to increasing prevalence of the condition in the region.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/14155

Asia Pacific is expected to grow at the fastest CAGR because of increase in the number of people showing the symptoms of Cushing syndrome, thus boosting the market growth of Cushing’s disease treatment market throughout the forecast period.

Some players of Cushing’s disease Treatment market includes CORCEPT THERAPEUTICS, HRA Pharma, Strongbridge Biopharma plc, Novartis AG, etc. However there are numerous companies producing branded generics for Cushing disease. The companies in Cushing’s disease treatment market are increasingly engaged in strategic partnerships, collaborations and promotional activities to capture a greater pie of market share.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cushing’s Disease Treatment Market Expecting Worldwide Growth by 2025 here

News-ID: 952340 • Views: 351

More Releases from Persistence Market Research

Recent research: Propylene Glycol Ether Market is expected to grow at a CAGR of …
The global Propylene Glycol Ether market is valued at US$1,604.1 million by the end of 2017 and is projected to reach US$2,088.4 million by the end of 2026, while growing at a CAGR of 3.0% during the forecast period. Persistence Market Research (PMR) provides an exclusive analysis of the global Propylene Glycol Ether Market in the latest report titled "Propylene Glycol Ether Market: Global Industry Analysis 2013-2017 and Forecast 2018-2026". Propylene Glycol Ether (PGE) is
Rapid Increase in End-use Adoption to Natural Food and Beverage Foaming Agent Ma …
A foaming agent is a surfactant, which when present in small amounts, facilitates the formation of a foam, or enhances its stability by inhibiting the coalescence of bubbles. Natural Food & Beverage foaming agent are food additives which are used maintain the uniform dispersion of gases in aerated foods. Foam is produced with the help of trapping the gas bubbles and it is offered either in form of solid or
Increasing Demand for Safflower Extract Market to Push Market Revenue Growth Thr …
Safflower Extract Market A study by PMR concludes that, "Safflower Extract Market: Global Opportunities, Challenges, Strategies and Forecasts 2026" has been added on Persistence Market Research. Safflower is an annual plant flourish in hot and dry condition, primarily in the western great plain area of the United States. It is also named as Catharanthus tinctorius L. (Botanical Name), Sallflower, False Saffron (because of Saffron like property), American Saffron, Alazor, etc. It is
Slimming Devices Market to Register Stellar Compound Annual Growth Rate Through …
Slimming Devices Market A study by PMR concludes that, "Slimming Devices Market: Global Opportunities, Challenges, Strategies and Forecasts 2025" has been added on Persistence Market Research. Obesity epidemic is reaching epic proportions worldwide. As per the data released by the World Health Organisation, there are more than 1.2 billion overweight adults, twenty years or older in the world today. This epidemic of obesity has even targeted children. According to the data released

All 5 Releases


More Releases for Cushing

Somatostatin Analogs Market Report 2018: Segmentation by Product (Octreotide, La …
Global Somatostatin Analogs market research report provides company profile for Chiasma, Ipsen Biopharmaceutical, Novartis, Peptron and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the basis of
Pituitary ACTH Hypersecretion (Cushing Disease) Industry Assessment And Therapeu …
Overview Cushing’s disease is a condition which results from hypersecretion of adrenocorticotropic hormone (ACTH) due to pituitary gland tumor. Symptoms include acne or skin infections, backache, mental changes (such as depression, anxiety, or changes in behavior), plethora, menstrual disorders and weight gain. Treatment includes radiation, chemotherapy, and use of certain hormone-inhibiting drugs.  Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740070-pituitary-acth-hypersecretion-cushing-disease-pipeline-review-h2-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Pituitary ACTH Hypersecretion (Cushing Disease) -
Cushing’s Disease Treatment Market to Develop Rapidly by 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease
Cushing’s Disease Treatment Market Estimated to Soar Higher During 2017 - 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease
New Report Examines the Growth of Cushing’s Disease Treatment Market Forecast …
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease
Oil Storage Market, Palm Oil Storage and Marketing, Capacity, Cushing Inventory, …
The global oil storage market is segmented based on material, fuel, product, and geography. Based on material, the market is categorized into steel, carbon steel, fiberglass reinforced plastic, and others. By fuel, it is classified into crude oil, gasoline, aviation fuel, middle distillates, liquefied natural gas (LNG), and liquefied petroleum gas (LPG). Based on product, the market is divided into open top, fixed roof, and floating roof. Geographic breakdown and